Abstract
As the most prevalent neurodevelopmental disorders in children, autism spectrum disorders (ASD) are characterized by deficits in language development, social interaction, and repetitive behaviors or inflexible interests. Contactin associated protein like 2 (CNTNAP2), encoding a single transmembrane protein (CNTNAP2) with 1331 amino acid residues, is a widely validated ASD-susceptible gene. Cntnap2-deficient mice also show core autism-relevant behaviors, including the social deficits and repetitive behavior. However, the cellular mechanisms underlying dysfunction CNTNAP2 and ASD remain elusive. In this study, we found a motif within the transmembrane domain of CNTNAP2 was highly homologous to the γ-secretase cleavage site of amyloid-β precursor protein (APP), suggesting that CNTNAP2 may undergo proteolytic cleavage. Further biochemical analysis indicated that CNTNAP2 is cleaved by γ-secretase to produce the CNTNAP2 intracellular domain (CICD). Virally delivery of CICD to the medial prefrontal cortex (mPFC) in Cntnap2-deficient (Cntnap2−/−) mice normalized the deficit in the ASD-related behaviors, including social deficit and repetitive behaviors. Furthermore, CICD promoted the nuclear translocation of calcium/calmodulin-dependent serine protein kinase (CASK) to regulate the transcription of genes, such as Prader Willi syndrome gene Necdin. Whereas Necdin deficiency led to reduced social interaction in mice, virally expression of Necdin in the mPFC normalized the deficit in social preference of Cntnap2−/− mice. Our results thus reveal a critical function of CICD and highlight a role of the CNTNAP2-CASK-Necdin signaling pathway in ASD.
Similar content being viewed by others
Introduction
Autism spectrum disorders (ASD) are the most prevalent neurodevelopmental disorders in children, with a group of heterogeneous clinical syndromes, characterized by deficits in language development, social interaction, and repetitive behaviors or inflexible interests.1 Over 70% ASD patients are accompanied with comorbidities, such as attention-deficit hyperactivity disorder (ADHD), epilepsy, anxiety, depression, sleep disturbance, gastrointestinal and immune problems.2,3 In recent decades, the incidence of ASD is steadily increasing up to 1/44 according to the report from the Center for Disease Control and Prevention (CDC) in 2021. However, the high heterogeneity in the clinical and genetic features of ASD greatly hampered the understanding of their genetic and pathological mechanisms.4,5
ASD is highly heritable disorder, and several hundred genes are associated with increased risk of developing ASD.6,7 The findings from genetics, neuropathology and therapeutics disciplines converge attentions on several potential common molecular or cellular pathways, including PI3K/mTOR signaling pathways, oxytocinergic activities and defective synaptic functioning.2 PI3K/mTOR signaling pathways contribute to synaptic protein synthesis and thereby altering synaptic functions, and closely linked to activation of some neuron surface receptors, such as N-Methyl-D-aspartic acid-type glutamate receptors (NMDARs), metabotropic glutamate receptors (mGluRs), and AMPA-type glutamate receptors (AMPARs).8,9 Moreover, mTOR inhibitors such as rapamycin and everolimus can ameliorate behavioral deficits in certain autistic animal models.10,11 Genetic variants in oxytocin (OXT) and oxytocin receptor (OXTR) have been reported to be linked to autism, and Oxt or Oxtr knockout mice exhibit ASD-associated behavioral abnormalities.12,13,14,15 As a neurotransmitter, dynamic alterations in OXT concentration and its receptors density may influence the neural circuit and thus affect the behavioral performance.14,16,17 Some typical animal models of ASD also have abnormal oxytocin system, and OXT treatment can effectively rescue the social deficit.18 Probable explanation is that OXT from the paraventricular nucleus (PVN) enhances the dopamine release in the ventral tegmental area (VTA), and ultimately activates the excitability of dopamine D1 neurons in the nucleus accumbens (NAc) to enhance social behavior.19 Recent studies have also highlighted the significance of synapse formation and stabilization, synaptic modification and functional connection establishment processes in ASD etiology.20 Abnormalities in synaptic proteins involved in cell adhesion, scaffolding, or signaling may underlie the etiology of ASD.21 For instance, neurexins and neuroligins are presynaptic and postsynaptic binding partners to mediate synapse formation and stabilization. In humans, variants in genes encoding neuroligins or neurexins have been associated with ASD.22
Contactin associated protein like 2 (CNTNAP2), a widely validated ASD risk gene,23,24,25,26 encodes CNTNAP2 protein with 1331 amino acid residues. CNTNAP2 is a single transmembrane protein of Neurexin superfamily, localized in the post-synaptic region with a large extracellular domain and a short intracellular domain.27 Cntnap2-deficient mice show core autism-relevant behaviors, including the social deficits and repetitive behavior.28 Functionally, CNTNAP2 is involved in the growth of synaptic spines, neuronal migration and neuronal network activity.29,30 RNAi-mediated knockdown of Cntnap2 globally decreases the dendritic arborization as well as spine development, resulting in a suppression of neural network activity. And loss of Cntnap2 in neurons causes reduction in interneurons number, and alterations in neuronal migration and cortical layer patterning. Furthermore, it is reported that repression of Cntnap2 expression in the prefrontal cortex leads to a decrease in the number of functional synapses and an imbalance of E/I balance.31 Nevertheless, the underlying cellular mechanisms are still unclear.
Previously, we identified a panel of differentially expressed genes in the hippocampus of Cntnap2−/− mice;32 however, how CNTNAP2 regulates the expression of these genes is unknown. Numerous single transmembrane proteins undergo two steps of proteolytic processing. The first cleavage at the extracellular juxtamembrane region releases a soluble extracellular fragment, and the second cleavage by γ-secretase within the transmembrane region produces an intracellular domain.33 For instance, Notch receptors undergo two sequential proteolytic cleavages upon ligand binding and release the Notch intracellular domain (NICD), which translocates to the nucleus and activates its target genes by forming a complex with transcription factor CBF1/Su(H)/Lag-1 or CSL.34,35,36 Furthermore, the amyloid-β precursor protein (APP) undergoes successive cleavage by β- and γ-secretases to generate the amyloid β protein (Aβ), the secreted APP (sAPP), and APP intracellular domain (AICD).37,38 AICD could translocate into the nucleus to regulate gene expression by forming a complex with Fe65 and Tip60.39
In this study, we found that a motif within the transmembrane domain of CNTNAP2 was highly homologous to APP’s γ-secretase cleavage site, suggesting that CNTNAP2 may undergo proteolytic cleavage. Our biochemical studies demonstrated that CNTNAP2 was first cleaved in extracellular juxtamembrane domain releasing a soluble extracellular fragment and a membrane-tethered 20KDa C-terminal fragment (CTF). The CTF was further processed by γ-secretase to generate the CNTNAP2 intracellular C-terminal domain (CICD). Overexpression of CICD in the mPFC of Cntnap2−/− mice rescued both social deficit and repetitive behaviors. We further found that CICD promotes the nuclear entry of calcium/calmodulin-dependent serine protein kinase (CASK) to regulate the expression of a panel of target genes. The Prader Willi gene Necdin is one of such target genes and partly responsible for the deficit of autism-related behaviors in Cntnap2−/− mice, as overexpression of Necdin in the mPFC of Cntnap2−/− mice normalized the social deficit.
Results
CNTNAP2 undergoes proteolytic cleavage
Proteolytic processing of many single transmembrane proteins such as Notch and APP34,36,39,40,41 to release the intracellular domain is required for their functions. We found that CNTNAP2 contains a VVIF motif within its transmembrane domain that is highly homologous to the VVIA of APP’s γ-secretase cleavage site (Fig. 1a). To investigate whether CNTNAP2 undergoes proteolytic cleavage, plasmid pRK5-HA-CNTNAP2-Flag (CNTNAP2 with an HA tag after signal peptide (SP) and a Flag tag at the C-terminus; Supplementary Fig. 1a, upper) was transfected into HEK293T cells, CNTNAP2 was expressed on the cell surface (Supplementary Fig. 1b). Western blot with the cell lysates showed a full length CNTNAP2 of ~170KDa as detected by the antibodies against CNTNAP2, C-terminal Flag tag or N-terminal HA tag (Fig. 1b). A band of ~20 KDa was also detected by the antibodies against CNTNAP2 or C-terminal Flag tag, but not by the antibody against N-terminal HA tag (Fig. 1b). We also detected the ~20 kDa fragment in a variety of brain regions by using the CNTNAP2 antibody (Supplementary Fig. 2a). The ~20 KDa fragment was immunoprecipitated by a Flag antibody and subjected to mass spectrometry (MS) analysis (Supplementary Fig. 2b). As shown in Supplementary Fig. 2c, multiple peptide fragments corresponding to the CNTNAP2 C-terminus were identified. Furthermore, a protein with a molecular weight slightly less than the full length CNTNAP2 was also detected in the culture medium by the antibody against HA tag but not by the antibody against the Flag tag (Fig. 1c). These data indicated that CNTNAP2 may undergo proteolytic cleavage, producing a soluble extracellular domain and a membrane-tethered 20 KDa C-terminal fragment (CTF).
The γ-secretase cleaves CNTNAP2 to generate CICD
CNTNAP2 contains a potential γ-secretase cleavage site (Fig. 1a). As γ-secretase is involved in the proteolytic cleavage of type I transmembrane proteins such as APP and Notch receptors,36,40,41,42 we then sought to investigate the roles of γ-secretase in the proteolytic processing of CNTNAP2. To this end, DAPT, a γ-secretase inhibitor, was added to the HEK293T cells transfected with pRK5-HA-CNTNAP2-Flag. DAPT treatment significantly increased the level of ~20 KDa CTF (Fig. 1d, left). The CTF of endogenous CNTNAP2 proteolytic product was also increased in the primary hippocampal neurons after DAPT treatment (Fig. 1d, right). These data suggest that the CTF is a potential substrate of γ-secretase.
Presenilins (PS1 and PS2) are the catalytic subunits of the γ-secretase complex, and knockout (KO) of PS1 and PS2 abolished γ-secretase activity.42 To further investigate the function of γ-secretase in the processing of CNTNAP2, PS1-expressing plasmid and pRK5-HA-CNTNAP2-Flag were transfected into PS1/2-double-KO MEF cells (NN cells).37 As shown in Figs. 1e, f, expression of PS1 significantly decreased the ~20KDa CTF level in the presenilins-deficient NN cells, further implicating the CTF as a substrate for γ-secretase.
We speculate that the fragment after γ-secretase processing is too small to be detected. Therefore, plasmid pRK5-CNTNAP2-GFP-Flag expressing EGFP between the Flag tag and the C-terminus of CNTNAP2 (Supplementary Fig. 1a, lower) was transfected into the NN cells, and a band of ~40 KDa corresponding to the EGFP-tagged CTF was detected. However, co-transfection of the PS1 generated a ~35 KDa fragment, which was abolished after treatment with DAPT or L-685485, two γ-secretase inhibitors (Fig. 1g–i). Further analyses by N-terminal sequencing and mass spectrum showed the N-terminal sequence of the cleaved C-terminal fragment as LVFLIR, corresponding to the ε-site of APP by γ-secretase cleavages43 (Supplementary Fig. 3). These results clearly demonstrated that the ~35KDa fragment is an EGFP-tagged CNTNAP2 intracellular domain (CICD) generated by the γ-secretase cleavage.
CICD rescues autism-related behaviors in Cntnap2 −/− mice
Cntnap2−/− mice showed core autism-relevant deficiency, including impaired social interaction and repetitive behaviors.28 To investigate the role of CICD in the ASD-relevant behaviors, recombination adeno-associated virus expressing CICD (rAAV-EF1a-CICD-2A-EGFP, AAV-CICD) or EGFP control (rAAV-EF1a-2A-EGFP, AAV-EGFP) (Supplementary Fig. 4a) was bilaterally infused into the mPFC of 4-week-old male WT or Cntnap2−/− mice, and behavioral tests were performed at 3 weeks after injection (Fig. 2a, b). The immunofluorescent signal of EGFP revealed the infection of AAV into neurons but not astrocytes and microglia (Supplementary Fig. 4b, c).
Animals were habituated in a three-chamber test (Supplementary Fig. 5) and the sociability test showed that while WT mice preferred to interact with the stranger mouse (S) than the object (O), Cntnap2−/− mice injected with AAV-EGFP did not differentiate the object and stranger mouse (Fig. 2c, d), consistent with previous reports.28 However, Cntnap2−/− mice injected with AAV-CICD in the mPFC spent significantly more time with the mouse than the object, and the social preference was comparable to that of WT mice (Fig. 2c, d).
A reciprocal social interaction test was also performed. Cntnap2−/− mice injected with AAV-EGFP spent significantly less time on reciprocal social interaction than WT mice (Fig. 2e). However, viral delivery of CICD to the mPFC improved the sociability in Cntnap2−/− mice and increased their reciprocal social interaction time to the comparable levels of WT mice (Fig. 2e).
Repetitive behavior is one of the core clinic symptoms in ASD.44 Consistent with previous reports,28 Cntnap2−/− mice injected with AAV-EGFP spent significantly longer time on grooming themselves as compared with the WT controls (Fig. 2f). Viral delivery of CICD to the mPFC significantly decreased the self-grooming behaviors in Cntnap2−/− mice to the level of WT controls (Fig. 2f). Taken together, our results indicated that overexpression of CICD in the mPFC rescued both social deficit and repetitive behaviors, suggesting a critical role of CICD in the autism-related behaviors.
CICD transcriptionally activates Necdin expression
Some single transmembrane proteins, such as APP and Notch receptors, are proteolytically cleaved to produce intracellular domains, which translocate into the nucleus to transcriptionally regulate gene expression.34,36,39 Previously by performing RNA-sequencing analysis, 99 significantly down-regulated genes and 90 significantly up-regulated genes were identified in the hippocampus of Cntnap2−/− mice.32 Among these genes, Necdin in the Prader-Willi syndrome (PWS) chromosomal region is the most notably changed gene (Fig. 3a), and patients with PWS also present with autism-related symptoms.45 Furthermore, Necdin was considered as a driver gene contributing to the ASD-like phenotypes in a mouse model of paternal 15q duplications.46
Necdin expression in the Cntnap2-/- mice was also significantly decreased at mRNA as well as protein levels in the mPFC (Fig. 3b, c; Supplementary Fig. 6a). Further, knockdown of Cntnap2 with siRNAs in N2a neuronal cells significantly downregulated Necdin (Fig. 3d, e; Supplementary Fig. 6b), whereas overexpression of CNTNAP2 increased the endogenous Necdin level (Fig. 3f, g). Interestingly, overexpression of CICD in N2a cells also significantly upregulated the mRNA and protein levels of endogenous Necdin (Fig.3f, g; Supplementary Fig. 6c). Consistently, viral injection of CICD to the mPFC of Cntnap2-/- mice also normalized the Necdin protein to the level of WT mice (Fig. 3h, i). Our results indicated that Necdin is a downstream target gene of CNTNAP2 and CICD mediates the effect of CNTNAP2 on activating the Necdin gene expression.
Necdin alleviates social deficit in Cntnap2 −/− mice
To determine the effects of Necdin on autism-related phenotypes, animals were habituated in a three-chamber test (Supplementary Fig. 7a, b) and then subjected to the sociability test. Both Necdin-deficient (Necdin-p/+m)47 and WT mice preferred to interact with the stranger mouse (S) than the object (O) (Fig. 4a); however, Necdin-p/+m mice spent significantly less time on interacting with a mouse and the preference index of Necdin-p/+m mice was significantly lower than WT mice (Fig. 4a, b). The reciprocal social interaction test further confirmed the reduced sociability in Necdin-p/+m mice (Fig. 4c). Nevertheless, no significant genotypic difference was found in the grooming test (Supplementary Fig. 7c).
In order to determine if Necdin deficiency is responsible for the autism-related deficits in Cntnap2−/− mice, AAV-EGFP or rAAV-EF1a-Necdin-2A-EGFP (AAV-Necdin) were injected into the mPFC of WT and Cntnap2-/- mice at the age of 4 weeks and the social behaviors and grooming were measured at the age of 7 weeks (Supplementary Fig. 8a). In the three-chamber test, animals were habituated (Supplementary Fig. 8b) and then subjected to the sociability tests. As shown in Fig. 4d and Supplementary Fig. 8c, overexpression of Necdin in the mPFC normalized the social deficits in Cntnap2−/− mice. Meanwhile, the social preference was also improved significantly (Fig. 4e). However, there was no effect on the repetitive behavior as measured with a grooming test (Supplementary Fig. 8d).
CASK regulates the transcription of Necdin
To understand how CICD regulates gene expression, we searched if any CNTNAP2-interactive proteins have regulatory function in transcription. To this end, CASK stands out as an interesting candidate. CASK, a membrane-anchored ASD-risk protein, translocates into the nucleus and interacts with transcription factors to regulate gene transcription.48,49 The interaction between CASK and CICD was confirmed by using a co-immunoprecipitation assay (Supplementary Fig. 9a). We then investigated the effect of CASK on Necdin gene expression. We found that overexpression of CASK increased the mRNA and protein levels of Necdin in N2a cells (Fig. 5a–c), and RNA interference of CASK decreased the expression of Necdin in N2a cells as well as in primary neurons (Fig. 5d–f).
A luciferase reporter plasmid containing Necdin promoter (−1 kb to TSS) was generated for transcriptional activation assay. Overexpression of CASK dose-dependently promoted the Necdin promoter activity (Fig. 5g, Supplementary Fig. 9b). Furthermore, N2a cells were transfected with pRK5-CASK-Myc, and CASK-bound DNA was immunoprecipitated by using a Myc antibody. Five pairs of primers, spanning the −844 bp to TSS of Necdin promoter, were used to amplify the CASK-bound DNA by using quantitative PCR (qPCR). As shown in Fig. 5h and Supplementary Fig. 9c, DNA fragments including the neuron-restrictive core promoter region of Necdin (−80 to −35 bp) were significantly enriched in cells expressing CASK-Myc.
CICD regulates Necdin expression by facilitating nuclear translocation of CASK
As a membrane-anchored protein, CASK can also shuttle into the nucleus to regulate gene expression.48 We then sought to investigate if CICD influence the nuclear distribution of CASK. To this end, the endogenous CASK in the cytoplasmic and nuclear fractions from N2a cells or mPFC were measured. As shown in Fig. 6a, b, RNA interference of Cntnap2 significantly inhibited the nuclear entry of CASK in N2a cells. Furthermore, the endogenous CASK in nucleus was also significantly decreased in the mPFC of Cntnap2−/− mice than WT mice (Fig. 6c, d). Conversely, the nuclear form of CASK was significantly increased after overexpression of full length CNTNAP2 or CICD (Fig. 6e, f).
As CASK binds to the PDZ-binding motif at the C-terminus of CNTNAP2,50 we therefore generated a mutant CICD without this PDZ-binding motif (CICDΔPDZ), which did not interact with CASK in the co-immunoprecipitation assay (Supplementary Fig. 9a). As shown in Fig. 6g, h, CICDΔPDZ failed to change the nuclear-cytoplasmic distribution of CASK. Consistently, CICDΔPDZ was unable to upregulate the Necdin expression as the full length CICD (Fig. 6i–k). A triplet of basic amino acids (RHK) in the N-terminus of CICD may serve as a potential nuclear localization signal (NLS) (Supplementary Fig. 10a). Therefore, we mutated RHK to AAA in CICD (namely 3A-CICD). 3A-CICD failed to promote the nuclear localization of CASK and subsequent up-regulation of Necdin expression (Fig. 6l–n; Supplementary Fig. 10b-c).
Immunofluorescence was also carried out to see the effect of CICD and its mutants on the subcellular localization of CASK. CASK was detected in the cytoplasm and peri-membrane when it was expressed alone in N2a cells. CASK was clearly identified in the nucleus when it was co-expressed with CICD. However, no CASK was detected in the nucleus when it was co-expressed with CICDΔPDZ or 3A-CICD. On the other hand, CICD and CICDΔPDZ were detected in both cytoplasm and nucleus, whereas 3A-CICD was only detected in the cytoplasm, indicating an important role for the triplet of basic amino acids (RHK) in the nuclear localization (Supplementary Fig. 10d).
Discussion
Our study revealed a critical role for CICD generated by γ-secretase cleavage of CNTNAP2 in the autism-related behaviors, as overexpression of CICD in the mPFC of Cntnap2−/− mice fully rescues the social deficit as well as repetitive behaviors. Mechanistically, CICD may function by promoting the nuclear distribution of CASK to regulate gene expression. Our study implicates three ASD-susceptible genes, CNTNAP2, Necdin and CASK, may participate in the autism-related behaviors through a common pathway (Fig. 7). Further, as many CASK-interactive proteins, such as neurexin, are also type I transmembrane proteins and involved in ASD;51 it will be intriguing to investigate if the pathway uncovered in this study is also related to the etiology of ASD induced by deletion/mutation of those genes.
Our data indicate that CNTNAP2 was initially processed at the extracellular region to generate the soluble extracellular domain and a membrane-tethered CTF fragment (~20KDa), which was further cleaved by the γ-secretase to generate CICD (Fig. 7). Recently, Martin-de-Saavedra et al. reported a similar finding. They found that CNTNAP2 underwent activity-dependent ectodomain shedding and released a soluble extracellular fragment (CNTNAP2 ectodomain), which is involved in the regulation of Ca2+ homeostasis and network synchrony.52 While our data indicate that CICD is largely, if not all, responsible for the autism-related behaviors, the CNTNAP2 ectodomain may underlie the epilepsy in Cntnap2−/− mice. These two complementary studies uncover that CNTNAP2 exert diverse functions through different proteolytic products.
CNTNAP2 ectodomain is detectable in human cerebrospinal fluid (CSF), and its level is reduced in the CSF of individuals with ASD.52 It deserves to investigate if and how ASD-related CNTNAP2 mutations affect the proteolytic processing of CNTNAP2 protein. We speculate that the variants residing around the γ-secretase site may only affect the production of CICD, but have no effect on the production of ectodomain. Patients with such mutations may only have ASD, in contrast, the patients with CNTNAP2 gene deletion have both ASD and epilepsy.
CASK belongs to the family of membrane-associated guanylate kinase (MAGUK) proteins. In general, MAGUK proteins target to neuronal synapses and affect the trafficking, targeting, and signaling of ion channels.53 Cao et al. demonstrated that RNA interference of CASK in the mPFC leads to impaired social memory in mice,54 implicating an important role for CASK in the etiology of ASD.
Recently, Gao et al. demonstrated that CNTNAP2 regulates CASK recruitment to the plasma membrane and stability through the PDZ-binding motif at the C-terminus of CNTNAP2.50 However, CASK not only involves in the targeting of synaptic protein but also contributes to the gene expression regulation.48 CASK interacts with Tbr-1 and CINAP to regulate the expression of genes, such as Reelin and NMDAR subunit 2b (NR2b), which may underlie its role in diseases such as ASD. However, it is still unknown how the nuclear-cytoplasmic distribution of CASK is regulated. In our study, we demonstrated that proteolytic cleavage production of CNTNAP2, CICD, promoted the nuclear entry of CASK protein, to regulate the transcription of downstream genes such as Necdin. The CICD-CASK interaction is important for the nuclear entry of CASK as CICDΔPDZ, lacking the C-terminal CASK-interactive domain, failed to change the nuclear-cytoplasmic distribution of CASK and the Necdin expression. Intriguingly, CASK also interacts with a variety of type I transmembrane proteins, and some of them, such as neurexin, are also involved in the etiology of ASD.51 It will be warranted to investigate if the CNTNAP2-CASK-Necdin signaling pathway uncovered in this study is also applicable to the etiology of ASD caused by mutations in other CASK-interacting type I transmembrane proteins. Nonetheless, we cannot totally exclude the possibility that CNTNAP2 regulates Necdin expression through other pathways.
Prader-Willi syndrome (PWS) results from the no expression of paternally inherited genes in chromosome 15q11-q13, which is a maternally imprinted region.55 PWS is characterized by hyperphagia, repetitive and compulsive behaviors, and cognitive impairment.56 Approximately 27% of PWS cases meet ASD diagnostic criteria; however, the underlying mechanism is still elusive.
Necdin, one of the genes located in the PWS region, is expressed in all postmitotic neurons and their precursor cells during neuronal development.57 Necdin protein plays an important role in brain development, such as proliferation of neural stem cells, maintenance of neuronal survival, neuronal migration and axon growth.58,59,60,61 Here, we demonstrated that Necdin-deficient mice exhibited social deficit, whereas Necdin rescued the social deficit in Cntnap2−/− mice. It has been reported that Necdin-deficient mice showed a reduction in oxytocin-producing neurons and alterations of perinatal serotonergic metabolism and development,62,63,64 which may partly underlie the ASD-related behavioral abnormality. Intriguingly, an excess amount of Necdin was also reported to induce ASD-related behaviors, which is probably caused by the cortical excitatory-inhibitory imbalance.46
Necdin, as one of CICD-CASK-regulated genes, can only rescue the social deficit in Cntnap2−/− mice yet has no effect on the repetitive behavior, indicating the two core deficits in ASD are controlled by different factors/pathways. Indeed, social deficit in Cntnap2−/− mice has been rescued by certain manipulations, such as suppression of mTOR pathway, administration of oxytocin, or modulation of excitation/inhibition balance in the mPFC. However, these manipulations do not affect the repetitive behaviors in Cntnap2−/− mice.32,65,66 Conversely, risperidone, the first FDA-approved drug for ASD, alleviates hyperactivity and rigid repetitive behaviors in Cntnap2−/− mice, but does not alter social deficit.28 Nevertheless, we found that CICD was able to fully normalize social deficit as well as repetitive behaviors in Cntnap2−/− mice. Therefore, compounds mimicking CICD may be a novel therapeutic strategy for the core deficits of ASD. And future studies are warranted to further identify the CICD-regulated genes involved in repetitive behaviors.
Materials and methods
Mice
Cntnap2+/- mice at the C57BL/6 J background were acquired from the Jackson Laboratory (#017482). Inter-crossing between Cntnap2+/- mice was used to produce Cntnap2−/− mice and wild-type (WT) mice. The genotyping was performed by PCR as previously described.32 The generation of Necdin-deficient mice at the C57BL/6 J background was described previously.47 After weaning, mice of same gender and genotypes were group-housed with 3–5 mice per cage under controlled conditions (temperature, 20 ± 2 °C; relative humidity, 50–60%; 12 h light/12 h dark cycle) and had ad-lib access to food and water. All procedures regarding the care and use of animals were approved by the Ethics Committee of School of Life Sciences, Central South University of China. All methods were performed in accordance with approved guidelines.
Cell culture and transfection
HEK293T cells (ATCC) were maintained in Dulbecco’s modified Eagle’s medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco). N2a cells (ATCC) were cultured in DMEM medium supplemented with 10% FBS, and mixed with OptiMem (Gibco) at volume ratio in 1:1. NN cells were maintained in DMEM supplemented with 15% FBS, 1% non-essential amino acid (NEAA, Invitrogen), 0.05‰ LIF (50 U/mL ESGRO Leukemia Inhibitory Factor, Millipore) and another 4 ul β-mercaptan ethanol (Sigma) per 500 mL right before use. All cells were authenticated and tested for mycoplasma contamination, and were maintained at 37 °C in an incubator containing 5% CO2. Plasmid and siRNAs were transfected into cells using Lipofectamine 2000 Reagent (Invitrogen) according to the manufacturer’s instructions.
Affinity purification of CICD
HEK293T cells were transfected with pRK5-HA-CNTNAP2-GFP-Flag plasmid, and treated with 5 µM MG132 (EMD) overnight at 48 h after transfection. The cell lysates were collected and pre-cleared with 200 µL of Sepharose 4B (Sigma) for 1 h at 4 °C. After centrifugation at top speed for 15 min, the supernatant was transferred into a fresh tube and incubated overnight with 20 µL anti-Flag M2 affinity gel (Sigma). The beads were harvested by centrifugation, washed extensively with lysis buffer at 4 °C, and boiled with 30 µL 1Xloading buffer. After centrifugation at top speed for 10 min, the supernatant was collected for SDS-PAGE.
Quantitative RT-PCR
Cells or tissues were extracted using TRIzol® reagent (Life technologies, USA) according to the manufacturer’s instruction. 2 μg of total RNA were reverse-transcribed using the RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher, USA; K1622). The mRNA levels (20 ng of total cDNA equivalents) were examined with qPCR using Fast SYBR™ Green Master Mix (Thermo Fisher, USA; 4385612) according to the manufacturer’s instructions by a C1000 touch Thermal Cycler. Primers used for qPCR were shown as follow: Gapdh forward primer: AGGTCGGTGTGAACGGATTTG; Gapdh reverse primer: TGTAGACCATGTAGTTGAGGTC A; Necdin forward primer: GAGGTCCCCGACTGTGAGAT; Necdin reverse primer: TGCAGG ATTTTAGGGTCAACATC; Cntnap2 forward primer: CCTTGGCACCTAGATCACTTG; Cntnap2 reverse primer: CCCCTCCAATGATAGCTGAGTTT; Cask forward primer: TGGAAG CTCTACGCTACTGC; Cask reverse primer: GTTTAACAGGTGCCGAGTTTTC. Primers used for ChIP-qPCR were shown as following: P1 forward primer: CAACACGCATGCGCAATATC; P1 reverse primer: GATGCGGCTTGGAGCTCTT; P2 forward primer: CTAGTTCTGTGCCATACAGGAGAC; P2 reverse primer: GCGGGGCTGATGCGATATT; P3 forward primer: ACTCATCATCATCATAAGGTACAGC; P3 reverse primer: TGTGAAGGTCCTGGAGAAAGAC; P4 forward primer: ACATGGATTTATCTCCAGTGTCTG; P4 reverse primer: GGAAAGCTGTACCTTATGATGATG; P5 forward primer: GATCATTTTCCACTAGAATCTTAACGGAAG; P5 reverse primer: GCCCCACATGAAAATGAGGGATAT.
Nuclear and cytoplasmic protein isolation
N2a cells on 6 cm plates were transfected with 1 μg expression construct (pRK5, pRK5-HA-CNTNAP2-Flag, pRK5-CICD or pRK5-CICDΔPDZ respectively) or 10 μL siRNAs (20 μM) using Lipofectamine 2000 Reagent (Invitrogen) according to the manufacturer’s instructions. At 48 h after transfection, cells were washed with cold 1XDPBS (Gibco) and harvested using a cell scraper. Cells were transferred to a 1.5 mL Eppendorf tube and spun at 3000 g for 5 min at 4 °C. After removal of the supernatant, cells were re-suspended in 200 μL cytoplasmic extraction reagent (CER, 10 mM HEPES or Tris PH7.5, 40 mM KCl, 2 mM MgCl2, 10% glycerol and 1×Protein Inhibitor Cocktail) and incubated for 10 min on ice. Further, cells were blown softly about 25–40 times with a 1 mL syringe until the suspension was thick. The suspension was centrifuged at 4,000 g for 5 min at 4 °C and the supernatant (cytoplasmic fraction) was transferred to a new Eppendorf tube. The pellet was washed twice with 1XDPBS. Thereafter, the pellet was re-suspended in 3 mL 0.25 M sucrose solution (0.25 M sucrose, 1 M MgCl2, 1 M HEPES PH 7.5) and transferred carefully to a 15 mL Falcon tube containing 3 mL 0.35 M sucrose solution (0.35 M sucrose, 1 M MgCl2, 1 M HEPES PH 7.5). Then, the density gradient centrifugation was done at 1430 g for 5 min at 4 °C. The supernatant was removed and the pellet (nuclear fraction) was re-suspended in 200 μL nuclear extraction reagent (NER, 10 mM HEPES or Tris PH7.5, 500 mM NaCl, 1%Triton-X100, 10% glycerol and 1×Protein Inhibitor Cocktail). The suspension was ultrasonicated on ice for 20 s and centrifugation for 15 min at 13,000 g. Then, the samples were mixed with 2×SDS lysis buffer and boiled for 10 min. After centrifugation for 5 min at 13,000 g, the supernatant (nuclear fraction) was transferred to a new Eppendorf tube.
The mPFC was dissected and cut into small pieces. After addition of cytoplasmic extraction reagent (200 μL per 60 mg), tissues were transferred into Dounce Tissue Homogenizer and fully homogenized. The homogenate was transferred to a 1.5 mL Eppendorf tube and spun at 1500 g for 5 min at 4 °C. The supernatant was left as cytoplasmic fraction, whereas the pellet was further processed as above.
Western blotting
The samples were mixed with 2×SDS lysis buffer (50 mM Tris–HCl at pH 6.8, 2% SDS and 10% glycerol) with 1×Protein Inhibitor Cocktail, boiled at 100 °C for 10 min. The supernatant was obtained by centrifugation at 13,000 g for 10 min and the protein concentration was determined using the PierceTM BCA protein Assay kit (Thermo Fisher). Proteins in lysates were separated by SDS-PAGE, transferred to PVDF membranes, and blocked in 5% skim milk that contained 0.1% Tween 20 at room temperature for 1 h. The membranes were immunoblotted with the corresponding antibodies overnight at 4 °C, and then were washed and incubated with horseradish peroxidase conjugate secondary antibodies at room temperature for 1 h. After washing, the bands were visualized using the Pierce™ ECL Western Blotting Substrate kit (Thermo Fisher) and band intensities were quantified by ImageJ. The antibodies were listed as following: CNTNAP2 (ab33994, Abcam), Necdin (ab18554, Abcam), Flag-tag (14793, CST), HA-tag (3724, CST), GFP (2555, CST), CASK (ab252540, Abcam), GAPDH (97166, CST), Histone H3(9715, CST), PS1 (ab15458, Abcam).
Chromatin immunoprecipitation (ChIP)
N2a cells were transfected with 3 μg plasmids (pRK5-Myc or pRK5-CASK-Myc) using Lipofectamine 2000 Reagent (Invitrogen) according to the manufacturer’s instructions. At 48 h after transfection, fresh 37% formaldehyde was added to cultured cells to a final concentration of 1%. After incubation at room temperature for 10 min, 1/20 volume of 2.5 M glycine was added to quench formaldehyde. The cells were rinsed twice with cold 1XDPBS (Gibco) and harvested using a silicon scraper. The cells were then transferred to a 1.5 mL Eppendorf tube and spun at 1350 g for 5 min at 4 °C. After removal of the supernatant, cells were re-suspended in 500 μL Lysis Buffer1 (50 mM Hepes-KOH, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton X-100) and incubated at 4 °C for 10 min. After spinning at 1,350 g for 5 min at 4 °C, each pellet was resuspended in 500 μL Lysis Buffer 2 (10 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA). After rocking gently at room temperature for 10 min, the nuclei were pelleted in tabletop centrifuge by spinning at 1350 g for 5 minutes at 4 °C. Each pellet was resuspended in each tube in 200 μL Lysis Buffer 3 (10 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% Na-Deoxycholate, 0.5% N-lauroylsarcosine). The suspension was sonicated with a microtip attached to Misonix 3000 sonicator in an ice water bath. 50 µL of 10% Triton X-100, 200 µL Lysis Buffer 3, 5 μL cocktail, and 5 μL anti-Myc (CST, 2276 S) were added to each sample and incubated overnight at 4 °C. 15 μL beads (Thermo Fisher) was added and incubated at 4 °C for 4 h. The beads were washed with 1 mL Wash Buffer (50 mM Hepes-KOH, 500 mM LiCl, 1 mM EDTA, 1% NP-40, 10% Na-Deoxycholate) and eluted with 100 µL elution buffer (50 mM Tris-HCl, 10 mM EDTA, 1% SDS) at 65 °C with agitation for 2-3 h. 3-4 µL of 25 mg/mL RNaseA was added into each sample and incubated at 65 °C with agitation for 4-5 h, then 2 µL of 10 mg/mL proteinase K was added and incubated at 55 °C with agitation for 4-5 h. 200 µL AMPure XP Beads (Beckman, A63881) was used to extract DNA for qPCR assay.
Luciferase reporter assays
HEK293T cells were plated on 24-well plates and transfected with 20 ng, 40 ng, 80 ng of pRK5-CASK, 5 ng pGL3-Necdin promoter-Luc and 10 ng of pCMV-β-gal. At 48 h after transfection, cells were washed twice with PBS and lysed with Reporter Lysis Buffer (Promega). The extracts were assayed for luciferase activity with the Luciferase Assay System (Promega). Luciferase activities were determined using SIRIUS luminometer (Berthold Detection Systems GmbH).
Three-chamber social interaction test
Male mice at the age of 6–8 weeks were used. Mice were habituated to the experimenter for at least 3 days prior to the start of the behavioral experiments. Animals were allowed to acclimate to the behavioral testing room for at least 1 h before the first trial begins. The apparatus was a clear Plexiglas box divided into three interconnected equally-sized interconnected chambers (left, center, right), mouse was able to access each chamber from the center through the retractable doorways. There are two phases in the three-chamber social interaction test: habituation and sociability.67
At habituation phase, we placed two plexiglas cages in left and right chambers, the position was counter balanced in order to avoid bias, and two identical objects were placed inside. A subject mouse was introduced into the central chamber, and was allowed to explore three chambers for ten min. During habituation, the subject’s position was tracked continuously with an automated tracking software.
At sociability phase, an age- and sex-matched stranger mouse was enclosed in a plexiglas cage so that the social interaction was only initiated by the test mouse. To measure the sociability, we placed the subject mouse into the central chamber, and allowed it to explore the three-chamber apparatus for ten minutes. The behaviors were recorded and Anilab Software (Anilab) was used to score the time that the subject mouse spent on sniffing or climbing upon each plexiglas cage. We used the following formulate to calculate the preference index: Preference index =Time exploring (stranger mouse – object) / Time exploring (stranger mouse + object).
Reciprocal interaction test
We placed a male mouse at the age of 6–8 weeks in a cage and allow it to habituate for 10 min. Then, a novel conspecific matched mouse according to genotype, age, sex, and/or treatment was placed in a neutral arena. The time spent in social interaction of both animals was measured by two independent observers blind to the genotypes, including touching, close following, nose-to-anus sniffing, nose-to-nose sniffing, grooming and/or crawling over/under each other.68
Grooming test
We placed a male mice at the age of 6–8 weeks in a Plexiglas column (20 cm diameter). The behaviors were recorded for 10 min after 10 min acclimation. The time spent on grooming themselves was measured by a researcher who is blind to the genotypes.
Stereotaxic injection
Adeno-associated viruses carrying genes for EGFP (rAAV-EF1a-EGFP-WPRE-hGH pA, AAV-EGFP), CICD (rAAV-EF1a-CICD-P2A-EGFP-WPRE-hGH pA, AAV-CICD) or Necdin (rAAV-EF1a-Necdin-P2A-EGFP-WPRE-hGH pA, AAV-Necdin) was used. AAV-EGFP (AAV2/9, 2.46 × 1012 genomic copies per mL), AAV-CICD (AAV2/9, 5.55 × 1012 genomic copies per mL), AAV-Necdin (AAV2/9, 5.61 × 1012 genomic copies per mL) were made by BrainVTA (Wuhan). WT or Cntnap2−/− mice (4 weeks old), randomly allocated for different virus injection, were anesthetized with isoflurane (induction 4%, maintenance 1%) and placed in a stereotaxic frame (RWD). The skull was exposed under antiseptic conditions and a small craniotomy was made with a thin drill over prefrontal cortex (typical coordinates: 1.98 mm anterior to Bregma; ±0.4 mm lateral to the midline). AAV-EGFP, AAV-CICD or AAV-Necdin were injected using a glass micropipette (tip diameter ~15 µm) attached to a Nanoliter 1000 pressure injection apparatus. Over a 10 min period, 0.2 µL of virus was injected at a depth of 1.65 mm from the Bregma. The pipette remained for 10 min at the end of infusion to allow virus diffusion. When pulled out, pipette remained for 1 min per 0.05 mm lift to localize virus. The mice were sutured and placed on a hot blanket until they woke up. Behavior experiments were conducted at 3 weeks after virus injection.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 9.3.0. Except behavior tests, all experiments were repeated at least three times. Data were presented as mean ± SEM and the exact statistical tests each experiment were stated in the Figure legend.
Data availability
The data that support the findings of this study are available from the corresponding author upon request.
References
Lai, M. C., Lombardo, M. V. & Baron-Cohen, S. Autism. Lancet 383, 896–910 (2014).
Jiang, C. C. et al. Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications. Signal Transduct. Target Ther. 7, 229 (2022).
Khachadourian, V. et al. Comorbidities in autism spectrum disorder and their etiologies. Transl. Psych. 13, 71 (2023).
Vorstman, J. A. S. et al. Autism genetics: opportunities and challenges for clinical translation. Nat. Rev. Genet. 18, 362–376 (2017).
Sahin, M. & Sur, M. Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders. Science 350, 6263 (2015).
Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431–444 (2019).
Wang, T. et al. Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders. Nat. Commun. 11, 4932 (2020).
Buffington, S. A., Huang, W. & Costa-Mattioli, M. Translational control in synaptic plasticity and cognitive dysfunction. Annu Rev. Neurosci. 37, 17–38 (2014).
Xu, F., Na, L., Li, Y. & Chen, L. Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci. 10, 54 (2020).
Tsai, P. & Sahin, M. Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex. Curr. Opin. Neurol. 24, 106–113 (2011).
Ehninger, D. & Silva, A. J. Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders. Trends Mol. Med. 17, 78–87 (2011).
Ferguson, J. N. et al. Social amnesia in mice lacking the oxytocin gene. Nat. Genet 25, 284–288 (2000).
Choleris, E. et al. An estrogen-dependent four-gene micronet regulating social recognition: a study with oxytocin and estrogen receptor-alpha and -beta knockout mice. Proc. Natl Acad. Sci. USA 100, 6192–6197 (2003).
Sala, M. et al. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol. Psychiatry 69, 875–882 (2011).
King, L. B., Walum, H., Inoue, K., Eyrich, N. W. & Young, L. J. Variation in the Oxytocin Receptor Gene Predicts Brain Region-Specific Expression and Social Attachment. Biol. Psych. 80, 160–169 (2016).
Green, L. et al. Oxytocin and autistic disorder: alterations in peptide forms. Biol. Psych. 50, 609–613 (2001).
Anpilov, S. et al. Wireless Optogenetic Stimulation of Oxytocin Neurons in a Semi-natural Setup Dynamically Elevates Both Pro-social and Agonistic Behaviors. Neuron 107, 644–655 (2020).
Choe, K. Y. et al. Oxytocin normalizes altered circuit connectivity for social rescue of the Cntnap2 knockout mouse. Neuron 110, 795–808 (2021).
Hung, L. W. et al. Gating of social reward by oxytocin in the ventral tegmental area. Science 357, 1406–1411 (2017).
Ecker, C., Spooren, W. & Murphy, D. G. Translational approaches to the biology of Autism: false dawn or a new era? Mol. Psych. 18, 435–442 (2013).
De Rubeis, S. et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209–215 (2014).
Sudhof, T. C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903–911 (2008).
Alarcon, M. et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am. J. Hum. Genet. 82, 150–159 (2008).
Arking, D. E. et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet. 82, 160–164 (2008).
Bakkaloglu, B. et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am. J. Hum. Genet. 82, 165–173 (2008).
Penagarikano, O. & Geschwind, D. H. What does CNTNAP2 reveal about autism spectrum disorder? Trends Mol. Med. 18, 156–163 (2012).
Poliak, S. et al. Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron 24, 1037–1047 (1999).
Penagarikano, O. et al. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147, 235–246 (2011).
Anderson, G. R. et al. Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development. Proc. Natl Acad. Sci. 109, 18120–18125 (2012).
Varea, O. et al. Synaptic abnormalities and cytoplasmic glutamate receptor aggregates in contactin associated protein-like 2/Caspr2 knockout neurons. Proc. Natl Acad. Sci. 112, 6176–6181 (2015).
Sacai, H. et al. Autism spectrum disorder-like behavior caused by reduced excitatory synaptic transmission in pyramidal neurons of mouse prefrontal cortex. Nat. Commun. 11, 5140 (2020).
Xing, X. et al. Suppression of Akt-mTOR pathway rescued the social behavior in Cntnap2-deficient mice. Sci. Rep. 9, 3041 (2019).
Lichtenthaler, S. F., Lemberg, M. K. & Fluhrer, R. Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments. EMBO J. 37, e99456 (2018).
Schroeter, E. H., Kisslinger, J. A. & Kopan, R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393, 382–386 (1998).
Kopan, R. & Ilagan, M. X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216–233 (2009).
Song, W. et al. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proc. Natl Acad. Sci. 96, 6959–6963 (1999).
Zhang, S. et al. A presenilin-1 mutation causes Alzheimer disease without affecting Notch signaling. Mol. Psyc. 25, 603–613 (2020).
Zhang, Y. & Song, W. Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis? Prog. Neurobiol. 153, 100–120 (2017).
Cao, X. & Sudhof, T. C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115–120 (2001).
De Strooper, B. et al. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518–522 (1999).
De Strooper, B. et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387–390 (1998).
Zhang, Z. et al. Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1. Nat. Cell Biol. 2, 463–465 (2000).
Tian, Y., Bassit, B., Chau, D. & Li, Y. M. An APP inhibitory domain containing the Flemish mutation residue modulates gamma-secretase activity for Abeta production. Nat. Struct. Mol. Biol. 17, 151–158 (2010).
Yap, C. X. et al. Autism-related dietary preferences mediate autism-gut microbiome associations. Cell 184, 5916–5931 (2021).
Bennett, J. A., Germani, T., Haqq, A. M. & Zwaigenbaum, L. Autism spectrum disorder in Prader-Willi syndrome: A systematic review. Am. J. Med. Genet A. 167A, 2936–2944 (2015).
Tamada, K. et al. Genetic dissection identifies Necdin as a driver gene in a mouse model of paternal 15q duplications. Nat. Commun. 12, 4056 (2021).
Lu, R., Dong, Y. & Li, J. D. Necdin regulates BMAL1 stability and circadian clock through SGT1-HSP90 chaperone machinery. Nucl. Acids Res. 48, 7944–7957 (2020).
Hsueh, Y. P., Wang, T. F., Yang, F. C. & Sheng, M. Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2. Nature 404, 298–302 (2000).
Wang, G. S. et al. Transcriptional modification by a CASK-interacting nucleosome assembly protein. Neuron 42, 113–128 (2004).
Gao, R. et al. CNTNAP2 stabilizes interneuron dendritic arbors through CASK. Mol. Psych.23, 1832–1850 (2018).
Hata, Y., Butz, S. & Sudhof, T. C. CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins. J. Neurosci. 16, 2488–2494 (1996).
Martin-de-Saavedra, M. D. et al. Shed CNTNAP2 ectodomain is detectable in CSF and regulates Ca(2+) homeostasis and network synchrony via PMCA2/ATP2B2. Neuron 110, 627–643 (2021).
Hsueh, Y. P. The role of the MAGUK protein CASK in neural development and synaptic function. Curr. Med. Chem. 13, 1915–1927 (2006).
Cao, X. et al. Inhibition of CASK Expression by Virus-mediated RNA Interference in Medial Prefrontal Cortex Affects Social Behavior in the Adult Mouse. Shinshu Med. J. 69, 45–52 (2021).
Goldstone, A. P. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol. Metab. 15, 12–20 (2004).
Cassidy, S. B., Schwartz, S., Miller, J. L. & Driscoll, D. J. Prader-Willi syndrome. Genet Med. 14, 10–26 (2012).
Gerard, M., Hernandez, L., Wevrick, R. & Stewart, C. L. Disruption of the mouse necdin gene results in early post-natal lethality. Nat. Genet. 23, 199–202 (1999).
Huang, Z., Fujiwara, K., Minamide, R., Hasegawa, K. & Yoshikawa, K. Necdin controls proliferation and apoptosis of embryonic neural stem cells in an oxygen tension-dependent manner. J. Neurosci. 33, 10362–10373 (2013).
Kuwako, K. et al. Disruption of the paternal necdin gene diminishes TrkA signaling for sensory neuron survival. J. Neurosci. 25, 7090–7099 (2005).
Kuwajima, T., Hasegawa, K. & Yoshikawa, K. Necdin promotes tangential migration of neocortical interneurons from basal forebrain. J. Neurosci. 30, 3709–3714 (2010).
Kruger, M., Ruschke, K. & Braun, T. NSCL-1 and NSCL-2 synergistically determine the fate of GnRH-1 neurons and control necdin gene expression. EMBO J. 23, 4353–4364 (2004).
Muscatelli, F. et al. Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum. Mol. Genet. 9, 3101–3110 (2000).
Dombret, C. et al. Loss of Maged1 results in obesity, deficits of social interactions, impaired sexual behavior and severe alteration of mature oxytocin production in the hypothalamus. Hum. Mol. Genet. 21, 4703–4717 (2012).
Matarazzo, V. et al. Necdin shapes serotonergic development and SERT activity modulating breathing in a mouse model for Prader-Willi syndrome. Elife 6, e32640 (2017).
Penagarikano, O. et al. Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Sci. Transl. Med. 7, 271–278 (2015).
Selimbeyoglu, A. et al. Modulation of prefrontal cortex excitation/inhibition balance rescues social behavior in CNTNAP2-deficient mice. Sci. Transl. Med. 9, eaah6733 (2017).
Bidinosti, M. et al. CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency. Science 351, 1199–1203 (2016).
Silverman, J. L., Yang, M., Lord, C. & Crawley, J. N. Behavioural phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 11, 490–502 (2010).
Acknowledgements
This work was supported by funding from National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770780 and 31972913; Key Research and Development Programs from Hunan Province, Grant/Award Number: 2021DK2001; Guangdong Key Project in ‘Development of New Tools for Diagnosis and Treatment of Autism’, Grant/Award Number: 2018B030335001; Strategic Priority Research Program of Central South University, Grant/Award Number: ZLXD2017004; The project has been funded in part with Independent Exploration and Innovation Project of Central South University, Grant/Award Number: 2018zzts393.
Author information
Authors and Affiliations
Contributions
J.-D.L. and W.S. conceived and designed the experiments, J.Z. and F.C. performed most of the experiments and analyzed the data. X.X., R.L. and K.W. performed the behavioral test of Necdin-deficient (Necdin-p/+m) mice. Analysis of gene expression in Cntnap2−/− mice was performed by Z.G., L.X., Q.Z., Y.Z. and M.X. performed cleavage and transcriptional assays and analyzed data. J.-D.L., J.Z., and W.S. wrote the manuscript, and all authors reviewed the manuscript. J.-D.L. and W.S. supervised the project.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, J., Cai, F., Lu, R. et al. CNTNAP2 intracellular domain (CICD) generated by γ-secretase cleavage improves autism-related behaviors. Sig Transduct Target Ther 8, 219 (2023). https://doi.org/10.1038/s41392-023-01431-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41392-023-01431-6
This article is cited by
-
Contactin-associated protein-like 2 (CNTNAP2) mutations impair the essential α-secretase cleavages, leading to autism-like phenotypes
Signal Transduction and Targeted Therapy (2024)